AGP Executive Report
Last update: 10 hours agoPharma & Biotech: FDA approved Ultragenyx’s Fayuvi, the first pediatric gene therapy for Sanfilippo syndrome type A (ages 2–5), while Lisata Therapeutics agreed to buy Marea Therapeutics and mAbxience teamed with Sandoz on an emicizumab biosimilar push. Paraguay Energy & Industry: ATOME PLC filed a Notice of Dispute and plans arbitration under the UK–Paraguay investment treaty over its Villeta low-carbon fertiliser project (US$665m). Agri & Supply Chains: FEFAC warned EU feed costs could jump as drought, Black Sea disruptions and EUDR sourcing constraints squeeze soybean meal availability—flagging Paraguay as low-risk for supply. Climate & Logistics: El Niño is expected to intensify, with Paraguay likely facing above-average rainfall and flood risk, while Itaipú opened gates for 10 days to manage Paraná River flows. Local Business & Culture: Asunción spotlighted Paraguay’s fast-growing music scene, and a sustainable fashion event (Casa MOLA Paraguay) brought textile players together. Security Watch: Analysis flags Tren de Aragua’s expansion in Brazil and tri-border risks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
